LINC-ROR and non-small cell lung carcinoma: Shi et al. elucidated that ROR was increased in cisplatin-resistant non-small cell lung cancer (NSCLC) and ROR overexpression enhanced DDP resistance via affecting cell growth, metastasis, autophagy and apoptosis in NSCLC [9].